Targeting mitochondria in ME/CFS and Long Haul COVID with ASHA-091
Asha Therapeutics presented exciting new data for their lead Parkinson's Disease therapeutic ASHA-091 in one of its secondary indications...
top of page
Recent News & Press Releases
Search
bottom of page